Contraception choice in adolescence

Barry E. Gidal, Mindl M. Messinger, Katherine Noe, C. L. Harden

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

An 18-year-old girl is a freshman in community college and has a history of focal epilepsy of left frontal origin due to cortical dysplasia. She is managed on oxcarbazepine and has remained seizure free in the past year. She informs you that she is sexually active and has been in stable relationship with her boyfriend in the past 6 months. She is asking you for advice on starting contraception. What form of contraception are you most likely to recommend to her? What will be your advice if she was on lamotrigine, topiramate, or levetiracetam?.

Original languageEnglish (US)
Title of host publicationControversies in Caring for Women with Epilepsy: Sorting Through the Evidence
PublisherSpringer International Publishing
Pages29-36
Number of pages8
ISBN (Electronic)9783319291703
ISBN (Print)9783319291680
DOIs
StatePublished - Jan 1 2016

Keywords

  • Adolescent
  • Catamenial epilepsy
  • Contraception
  • Enzyme induction
  • Hormonal contraceptives
  • Intrauterine device
  • Lamotrigine
  • Levetiracetam
  • Oral contraceptive pills
  • Oxcarbazepine
  • Partial epilepsy
  • Pregnancy
  • Topiramate

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Contraception choice in adolescence'. Together they form a unique fingerprint.

  • Cite this

    Gidal, B. E., Messinger, M. M., Noe, K., & Harden, C. L. (2016). Contraception choice in adolescence. In Controversies in Caring for Women with Epilepsy: Sorting Through the Evidence (pp. 29-36). Springer International Publishing. https://doi.org/10.1007/978-3-319-29170-3_4